Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurementPsychedelics · 2026-12-01Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery modelPsychedelics · 2026-12-01Pupil-DLC: An open-source deep learning pipeline for scalable, marker-less tracking of pupil dynamics across conscious and unconscious states.Journal of neuroscience methods · 2026-11-01Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depressionJournal of Affective Disorders · 2026-11-01Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in ratsPharmacology Biochemistry and Behavior · 2026-10-01Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. AdultsAmerican Journal of Preventive Medicine · 2026-10-01Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled TrialClinicalTrials.gov · 2026-09-15Psilocybin and ayahuasca in treatment-resistant depression: clinical evidence, methodological constraints and ethical challenges: a narrative reviewFrontiers in Psychiatry · 2026-09-155-HT2A receptor activation is dispensable for psilocybin-induced fear extinction and neuroplasticity in mice.Chinese medical journal · 2026-09-15Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's DiseaseClinicalTrials.gov · 2026-09-15PRoMiSS: Psilocybin and the Role of Music in Set and SettingClinicalTrials.gov · 2026-09-15Targeting Reward Circuits: Psilocybin as a Novel Therapy for Residual AnhedoniaClinicalTrials.gov · 2026-09-15Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder: A Randomized Controlled TrialClinicalTrials.gov · 2026-09-15Resetting the hippocampal buffer: a neurocognitive account of psychedelic therapy for anxiety-related psychopathology.Psychopharmacology · 2026-09-15MDMA and Psilocybin Regulate Oligodendrocyte-Lineage Cell Numbers and Anxiety-Like Behaviors in a Rat Model of Fear.Biological psychiatry · 2026-09-15Psychedelics and the Extracellular Matrix: Rewiring Neuroplasticity and Metaplasticity for Next-Generation Psychiatric Therapies.Biological psychiatry · 2026-09-15Correlation of Ketamine and Classic Psychedelics with Pain-Related Neural Connectivity: A Scoping Review of Clinical Experiments on a Potential Therapeutic Target Concerning Ketamine and Classical Psychedelics Administration for Pain ReliefPsychedelic Medicine · 2026-09-14A Phase 1b Study to Evaluate the Safety and Tolerability of MLS101 Treatment for Premenstrual Dysphoric Disorder (PMDD)ClinicalTrials.gov · 2026-09-14Pilot Study on the Effects of Psilocybin on Belief Updating and Insight FormationClinicalTrials.gov · 2026-09-14Psilocybin Administration With 5-HT1a BlockadeClinicalTrials.gov · 2026-09-14Neural correlates and behavioral outcomes of aesthetic chills and their prosthetic augmentationPsyArXiv · 2026-09-13Implications of Potential US FDA Approval of Psychedelics or Psychedelic-Adjacents Such as Ibogaine for Pharmacy in Japan.Cureus · 2026-09-13[The use of psychedelics in psychiatry].Orvosi hetilap · 2026-09-13Modulating the Thermodynamics and Kinetics of Psychedelics at Serotonin Receptors via Terahertz WavesThe Journal of Physical Chemistry B · 2026-09-12Lifetime classic psychedelics use is associated with positive environmental attitudes and adopting a vegetarian dietScientific Reports · 2026-09-11Psilocybin and Chronic Neuropathic and Centralized Pain: Converging Mechanisms in Central Sensitization, Neuroplasticity, and Network OrganizationAnesthesia Research · 2026-09-11Characterizing Psychedelic-Evoked Familiarity: A Comparative Study with Autobiographical and Déjà Vu Experiences.Journal of psychoactive drugs · 2026-09-11TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance TherapyClinicalTrials.gov · 2026-09-11Multilevel Mechanisms and Clinical Efficacy of Psilocybin in Depression Treatment: A Systematic ReviewInternational Journal of Molecular Sciences · 2026-09-10Cardiac Arrhythmia Associated with Psychoactive Drugs: An analysis of the FDA Adverse Event Reporting SystemmedRxiv · 2026-09-10Psilocybin restores spatial memory but not fronto-hippocampal synchrony in a rat model of Alzheimer's disease.Neuroscience research · 2026-09-10What Is Psilocybin?JAMA · 2026-09-10Psilocybin-associated microRNA changes in the pig brain: Establishing an nCounter pipeline for cross-species microRNA quantification.European journal of pharmacology · 2026-09-10Psilocybin.JAMA · 2026-09-10Psilocybin selectively suppresses novelty-induced grooming via 5-HT2B receptors: A microstructure analysis in Wistar rats.Progress in neuro-psychopharmacology & biological psychiatry · 2026-09-09Psychedelic 4-AcO-DMT attenuated looming-induced freezing behaviors by activating PrL CaMKIIα neurons in mice.Molecular psychiatry · 2026-09-09A Two-Threshold Model of Psilocybin Response Explains Variability in Psychedelic-Assisted Therapy for Treatment-Resistant DepressionResearch Square · 2026-09-09Craving Reduction and Smoking Outcomes in Psilocybin-Assisted and Standard Cessation Care.Revista brasileira de psiquiatria (Sao Paulo, Brazil: 1999) · 2026-09-09A Randomized Double-blinded Controlled Trial for the Treatment of Persisting Symptoms After Concussion With Psilocybin-assisted Therapy: A Safety and Feasibility TrialClinicalTrials.gov · 2026-09-09A Double Blind, Randomized Trial Investigating the Safety, Feasibility, and Mechanisms of Psychedelics in Healthy Older Adults With Low Well-being as Moderated by Biomarkers for Preclinical Alzheimer's DiseaseClinicalTrials.gov · 2026-09-09Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner ViolenceClinicalTrials.gov · 2026-09-08Mystical but not challenging experiences predict symptom improvement after psilocybin for treatment-resistant OCDFrontiers in Psychiatry · 2026-09-08Psilocybin as a treatment for repetitive mild head injury: evidence from neuroradiology and molecular biologyCommunications Biology · 2026-09-08Who Is Reached by Supervised Psilocybin Services? Oregon Services Versus National Psilocybin UsemedRxiv · 2026-09-07Brain-wide reconfiguration of burst firing by psilocybin reveals 5-HT2A-dependent circuit dynamicsbioRxiv · 2026-09-07Psilocybin as an emerging anxiolytic: mechanisms, evidence, and open questions.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-09-06Daily briefing: Psilocybin blocks side-effect of chemotherapy in mice.Nature · 2026-09-04Psilocybin-induced changes in electroencephalography link acute and long-term effects.Journal of psychopharmacology (Oxford, England) · 2026-09-04One dose of Psilocybin modulates Brain Activity among Depressive patients: Preliminary Neuroimaging Results from the PSILODAC StudyEuropean psychiatry: the journal of the Association of European Psychiatrists · 2026-09-04Effects of Psilocybin in Obsessive Compulsive DisorderClinicalTrials.gov · 2026-09-04Pilot Study of Serotonin 2A Receptor (5-HT2A) Agonist Psilocybin for Depression in Patients With Mild Cognitive Impairment or Early Alzheimer's DiseaseClinicalTrials.gov · 2026-09-04Psilocybin and Affective Function in Chronic Lower Back Pain DepressionClinicalTrials.gov · 2026-09-04Psilocybin and MDMA for Post-traumatic Stress Disorder (PTSD)ClinicalTrials.gov · 2026-09-04A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress DisorderClinicalTrials.gov · 2026-09-04Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence in Patients Diagnosed With Early-stage Breast Cancer and Ovarian Cancer in RemissionClinicalTrials.gov · 2026-09-04Psilocybin prevents chemotherapy-induced peripheral neuropathy through mitochondrial trafficking preservation.Science (New York, N.Y.) · 2026-09-03Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease: a Pilot StudyClinicalTrials.gov · 2026-09-03A response to the letter to editor: Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy.Journal of affective disorders · 2026-09-02Through the Looking-Glass: A Scoping Review of Psychological Mechanisms of Psychedelic-Assisted Therapy for Substance Use DisordersCurrent Addiction Reports · 2026-09-02High vs. Low-Dose Group-Based Psilocybin-Assisted Therapy (PAT) With or Without Mindfulness-Based (MB) Preparation and Integration for Demoralization in Adults With Advanced Cancer (PAT-MIND): A Pilot Feasibility 2x2 Factorial Multisite TrialClinicalTrials.gov · 2026-09-02Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for Alcohol Use DisorderClinicalTrials.gov · 2026-09-02The Role of the Subjective Experience in Supporting Positive Effects Following Psilocybin: a Randomized, Controlled Clinical Trial Using Risperidone in Healthy AdultsClinicalTrials.gov · 2026-09-02Psilocybin-Assisted Therapy for Physician Well-Being and Burnout: Feasibility, Safety, Clinical Effectiveness and Biomarkers of Response [PAT-B (Psilocybin-Assisted Therapy for Physician Well-Being and Burnout)]ClinicalTrials.gov · 2026-09-02Age and Cannabis Co-Use Are Associated with Differences in Experience and Perceived Benefits of Psilocybin: A Retrospective Study.Journal of psychoactive drugs · 2026-09-02Psilocybin, From Ancestral Use to Therapeutic Potential: A Multidimensional Review of Its Pharmacological Basis and Current Perspectives.Human psychopharmacology · 2026-09-01Patterns of Psychedelic Use in Italy: Insights from the Global Psychedelic SurveyClinical Neuropsychopharmacology and Addiction · 2026-09-01Beyond Efficacy Signals: Regulatory, Methodological, and Translational Challenges in Clinical Research on Ketamine and Psilocybin in PsychiatryPsychiatry International · 2026-09-01Surrender, disidentification, and reappraisal: a qualitative comparison of psilocybin responders and non-responders in treatment-resistant OCDFrontiers in Psychiatry · 2026-09-01Factors Associated with Intentions to Use Psilocybin for Mental Health in Relation to Psychotherapy, Psychiatric Medications, and Natural/Synthetic Options.Journal of psychoactive drugs · 2026-09-01Mycotoxins in Basidiomycete Mycelium and Fruiting Bodies: Implications for Eu Novel Food Assessment and Selected International Regulatory Frameworks.Comprehensive reviews in food science and food safety · 2026-09-01AMCP Market Insights: Optimizing managed care approaches to treatment-resistant depression.Journal of managed care & specialty pharmacy · 2026-09-01Single-crystal structure determination of psilocybin after dehydration.Acta crystallographica. Section C, Structural chemistry · 2026-09-01Therapeutic potential of classic and non-classic psychedelics in neurodevelopmental disorders: Opportunities and challenges.Pharmacological research · 2026-09-01Comparing synthetic and biological therapy for the treatment of cluster headache: what is needed and when?Expert review of neurotherapeutics · 2026-09-01Active placebo control interventions in pharmacological trials: a scoping review of the development process and a terminological analysis.Journal of clinical epidemiology · 2026-09-01Psychedelics stores, their regulation and public health: knowledge, perceptions, attitudes and opinions of Canadians.The International journal on drug policy · 2026-09-01CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-09-01Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01A Nature-Themed Video Intervention Increases Nature Relatedness in Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01A suite of engineered mice for interrogating psychedelic drug actions.Nature neuroscience · 2026-09-01Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat Stress.Neuropsychopharmacology reports · 2026-09-01Balancing safety and access in Oregon's psilocybin services.The International journal on drug policy · 2026-09-01Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposases.Metabolic engineering · 2026-09-01Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic Review.Journal of clinical psychology · 2026-09-01Cardiovascular effects associated with acute recreational drug toxicity presentations to the emergency department: a European drug emergencies network (Euro-DEN plus) study.Clinical toxicology (Philadelphia, Pa.) · 2026-09-01HORMONAL MODULATION OF PSILOCYBIN RESPONSIVITY ACROSS THE FEMALE REPRODUCTIVE LIFESPANInternational Journal of Innovative Technologies in Social Science · 2026-08-31PSYCHEDELICS IN THE TREATMENT OF POST-TRAUMATIC STRESS DISORDER AND DEPRESSION: A REVIEW OF CLINICAL TRIALSInternational Journal of Innovative Technologies in Social Science · 2026-08-31Can psilocybin help a patient with chronic depression?Unknown journal · 2026-08-31PRISMatic: A Phase 1b Randomized, Double-Armed, Parallel-Group, Placebo-Controlled Trial of Psilocybin Efficacy With or Without Pimavanserin PretreatmentClinicalTrials.gov · 2026-08-31NeuroGuard: Psilocybin Trial for Preventing Chemo-induced NeuropathyClinicalTrials.gov · 2026-08-31An 8-week Phase 2 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-assisted-psychotherapy in Adults With Cannabis Use Disorder: A Proof-of-Concept StudyClinicalTrials.gov · 2026-08-31Differential effects of psilocybin derivatives on fentanyl-induced conditioned place preference in male and female mice.Journal of psychopharmacology (Oxford, England) · 2026-08-30A randomized crossover trial comparing the acute physiological and psychological effects of botanical formulations of oral psilocybin, oral psilocin, and sublingual psilocin.Journal of psychopharmacology (Oxford, England) · 2026-08-29Nursing education for emerging psychedelic-assisted therapy: A role-calibrated curriculum approach.Nurse education today · 2026-08-28Oregon's state-regulated psilocybin services: Early real-world safety signals.Journal of psychopharmacology (Oxford, England) · 2026-08-28Psilocybin-Assisted Psychotherapy for Posttraumatic Stress Disorder in Military Veterans: A Pilot Feasibility StudyClinicalTrials.gov · 2026-08-28Oncology Providers' Perspectives on Psychedelic-Assisted Therapy.The American journal of hospice & palliative care · 2026-08-28Development of a Physiologically Based Pharmacokinetic/Pharmacodynamic Model of Psilocybin/Psilocin from Psilocybe cubensis (Magic Mushroom) in Treatment-Resistant Depression.European journal of drug metabolism and pharmacokinetics · 2026-08-28A Randomised, Placebo Controlled Trial of Psilocybin in Treatment Resistant Depression: A Feasibility StudyClinicalTrials.gov · 2026-08-28Psilocybin enhances sociability only in altered behavioural state and does not need an awake experience to be effectiveNature Communications · 2026-08-27“Am I a candidate for magic mushrooms?” A mystery shopper study of Oregon psilocybin service centersHealth Affairs Scholar · 2026-08-27A dominant frontoparietal beta oscillatory brain state in the days after psilocybin and 5-MeO-DMTbioRxiv · 2026-08-27Pilot study comparing the effects of high dose THC to high dose psilocybin and placebo in the set and setting of a classic psychedelic therapy session.Psychopharmacology · 2026-08-27Medical and Psychiatric Consultation for Patients Considering State-Regulated Psilocybin Services: A Risk-Reduction Model and Two Illustrative CasesResearch Square · 2026-08-26Aquahenosis: a non-pharmacological altered state of consciousness induced by floatation-REST in individuals with anxiety and depression.Neuroscience of consciousness · 2026-08-26Mystical and affective features of naturalistic psychedelic experiences: A comparison of dictionary-based and LLM-based text analysis methodsResearch Square · 2026-08-25Psilocybin collapses visual change detection and drives cortical dynamics toward a state of surprisebioRxiv · 2026-08-25Beyond head-twitch response: Acute psilocybin affects spontaneous behaviors in rats in a dose-dependent manner.Journal of psychopharmacology (Oxford, England) · 2026-08-25Toward an Optimal Framework for Psilocybin Regulation: A Comparison of State Regulatory Approaches Across Key Dimensions.The Journal of legal medicine · 2026-08-25JAMA study examines Oregon's psilocybin services modelMental Health Weekly · 2026-08-24Appetite for change: How nutritional state and ventral striatal dopamine shape psilocybin effects on cognitive flexibilitybioRxiv · 2026-08-23Distinct response of resting-state brain networks to psilocybin in autismmedRxiv · 2026-08-22Adverse Effect-Related Language in Recreational Psychedelic and non-Psychedelic Substance Experience Reports.Journal of studies on alcohol and drugs · 2026-08-22Complex Fatal Self-Harm Under Psilocybin Intoxication: Suicidal Manner of Death or Not?Academic forensic pathology · 2026-08-21The trials of translating psilocybin treatment from research to practice.Nature medicine · 2026-08-21Exploring Psychedelics as Novel Therapeutics for Smoking Cessation: Mechanistic Insights from Animal StudiesVCU Scholars Compass (Virginia Commonwealth University) · 2026-08-21Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression: A Pilot Randomized Clinical TrialClinicalTrials.gov · 2026-08-21Psilocybin lengthens hippocampal sharp wave ripplesbioRxiv · 2026-08-20Low-dose lysergic acid diethylamide alters subjective visual perception but not visual contrast surround suppression.Neuroscience of consciousness · 2026-08-20Psilocybin in the Treatment of Methamphetamine Use DisorderClinicalTrials.gov · 2026-08-19Level of Preparedness to Use Psilocybin Among Individuals Seeking Psychedelic Risk Reduction: A retrospective study of a pilot psychiatric consultation servicemedRxiv · 2026-08-19The subtle science: a systematic review of psilocybin magic mushroom and truffle microdosingFrontiers in Psychiatry · 2026-08-19Safety and Mental Health Outcomes of Oregon State-Regulated Psilocybin ServicesJAMA Network Open · 2026-08-19Sex Differences in Acute Responses to Psychedelics: Evidence for Greater Subjective Intensity and Impairment in Female ParticipantsbioRxiv · 2026-08-19Prospective real-world evidence of mental health outcomes following supervised psilocybin services within Oregons state-regulated modelmedRxiv · 2026-08-19Psilocybin in Chronic Low Back Pain: An Integrative Study of Lab-Based Mechanisms and Real-World Physical Therapy OutcomesClinicalTrials.gov · 2026-08-19An Exploratory Pilot Study of Palliadelic Treatment to Reduce Psychological Distress in People With Pancreatobiliary and Other Advanced Gastrointestinal CancersClinicalTrials.gov · 2026-08-19Psychedelics align brain activity with context.Nature · 2026-08-19The Abuse Liability of Classic Psychedelics: A Methodological Critique and Assessment of the Quality of Evidence of Recent StudiesCurrent Addiction Reports · 2026-08-18Assessing Canadian Policy Readiness for Psychedelic-Assisted Therapy in Cancer CareUnknown journal · 2026-08-17Psilocybin-assisted psychotherapy for substance use disorders as a complex intervention: A systematic review of efficacy, mechanisms and psychotherapeutic frameworks.Journal of psychopharmacology (Oxford, England) · 2026-08-17An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in LifeClinicalTrials.gov · 2026-08-17Defining 'psychedelic'.Journal of psychopharmacology (Oxford, England) · 2026-08-17Subacute and long-term changes in cognitive functioning after administration of classic psychedelics, MDMA and ketamine: A systematic review of clinical and preclinical evidence.Neuroscience and biobehavioral reviews · 2026-08-14The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young AdultsClinicalTrials.gov · 2026-08-14Safety for Home Administration of Microdose Psilocybin UseClinicalTrials.gov · 2026-08-14A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in VeteransClinicalTrials.gov · 2026-08-14Ayahuasca and Salvia divinorum as contrasting modes of consciousness reorganization: Implications for psychedelic-assisted psychotherapyJournal of Psychedelic Studies · 2026-08-13Efficacy and Safety of Psychedelic Microdosing on Psychological Outcomes in Healthy Adults: A Systematic Review and Meta-analysis.CNS drugs · 2026-08-13Psilocybin asymmetrically modulates outcome-based choice and cortical processing under uncertaintybioRxiv · 2026-08-13Role of Experience, Conscious Awareness, and Plasticity in Psilocybin's Behavioral Effects - Follow-Up Study (The RECAP 2 Study)ClinicalTrials.gov · 2026-08-13Processing Intergenerational Trauma With Psilocybin-Assisted TherapyClinicalTrials.gov · 2026-08-13The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive DisorderClinicalTrials.gov · 2026-08-13PsiloStudy: A Phase 2 Single-site, Double-blind, Placebo-controlled, Randomized Clinical Trial With an Open-label Extension Phase to Examine the Safety, Subjective Experiences, Acute Effects, and Suitability of Psilocybin Combined With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD)ClinicalTrials.gov · 2026-08-13Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder: A Double-Blind, Dose-Comparison Concurrent Control Randomized TrialClinicalTrials.gov · 2026-08-13Psychedelic integration beyond the verbal: participatory-imaginal processing as a hypothesis-generating therapeutic frameworkFrontiers in Psychiatry · 2026-08-12Investigating the Effects of Psilocybin on Cognitive Flexibility in Touchscreen and Naturalistic Variations of the Probabilistic Reversal Learning TaskbioRxiv · 2026-08-12Real-world use, safety, and mental health efficacy of regulated psilocybin services in Oregon and ColoradomedRxiv · 2026-08-12Exploring the In Vitro Effect of Psilocybin on the Composition and Metabolic Activity of Gut Microbiota in Individuals with Severe AnxietyDrugs and Drug Candidates · 2026-08-12Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)Journal of Clinical Medicine · 2026-08-12TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer SurvivorsClinicalTrials.gov · 2026-08-12Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and SuicidalityClinicalTrials.gov · 2026-08-12Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring OpioidsClinicalTrials.gov · 2026-08-12A Phase 2a, Placebo-Controlled Randomized, Double-Blind Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety DisorderClinicalTrials.gov · 2026-08-12Psychedelic Therapy for DepressionUnknown journal · 2026-08-11Effects of naturalistic psychedelic use on executive functioning: An online survey of lifetime history and recent use in university students.Progress in neuro-psychopharmacology & biological psychiatry · 2026-08-11Psychedelics and astrocytes: a hypothesis-driven perspective on neuro-glial integration, network plasticity, and neuroimmune reprogramming.Molecular psychiatry · 2026-08-11Psilocybin Recovery Intervention for Stopping Methamphetamine UseClinicalTrials.gov · 2026-08-11Effects of Psilocybin in Patients With Amyotrophic Lateral SclerosisClinicalTrials.gov · 2026-08-11Could Psilocybin Be the Key to Treating Anorexia? -Breaking the Mind's Most Stubborn LoopUnknown journal · 2026-08-10Circulating MicroRNAs and Their Associations with Neurotrophic, Inflammatory and Glutamate Markers in Healthy VolunteersbioRxiv · 2026-08-10Temporal effects of a single oral dose of psilocybin on plasma circulating miRNAs in healthy young adultsbioRxiv · 2026-08-10Psilocybin acutely dissociates cognitive and affective empathy, with empathic concern predicting persisting positive psychological effectsbioRxiv · 2026-08-10An Open-Label Trial Protocol to Test Menstrual Cycle Effects and Tolerance to Low-Dose Psilocybin in Healthy Menstruating Persons.Pharmacology · 2026-08-10An Investigation of Strategies to Understand and Optimize the Antidepressant Effects of Psilocybin (The OPTIMIZE Study)ClinicalTrials.gov · 2026-08-10A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord InjuryClinicalTrials.gov · 2026-08-10A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10A Multicenter Phase 1 Safety and Tolerability Trial of Psilocybin in Healthy Older AdultsClinicalTrials.gov · 2026-08-10Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot StudyClinicalTrials.gov · 2026-08-10'So many relationships in the room': Participant perspectives on the affordances and challenges of co-therapy in psychedelic assisted therapy.Psychology and psychotherapy · 2026-08-10Advanced research eyes potential of psychedelics for complex casesMental Health Weekly · 2026-08-07Microdosing psychedelics: What, why, when, and how often? Insights from an international survey of people who use psychedelics.The International journal on drug policy · 2026-08-07Feasibility and Tolerability of Psilocybin for Phantom Limb Pain.The journal of pain · 2026-08-07Impact of Psilocybin on Motor Function in Healthy Participants: A Phase 1, Randomised, Triple-Blind, Dose-Finding Study.CNS drugs · 2026-08-07The Efficacy of Psilocybin Therapy for Depression in Parkinson's DiseaseClinicalTrials.gov · 2026-08-07Open Label Psilocybin Brain Stimulation and Imaging Pilot StudyClinicalTrials.gov · 2026-08-07Correspondence: "Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy".Journal of affective disorders · 2026-08-06Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.Nature medicine · 2026-08-06Single Dose Psilocybin for a Post-surgical Trauma Inpatient Population for Pain, Mood, and Opioid Use DisorderClinicalTrials.gov · 2026-08-06Psilocybin for Treatment-Resistant Depression in Autism: a Pilot Trial With Pre-Post Brain and Cognitive Measurement to Understand MechanismClinicalTrials.gov · 2026-08-06An Exploratory Study of Feasibility, Efficacy, and Mechanisms of Mindfulness-Assisted Psychedelic TherapyClinicalTrials.gov · 2026-08-06Mapping excitatory synaptic plasticity evoked by single-dose psilocybin in micebioRxiv · 2026-08-05Role of β-Arrestin2 Signaling in Neuropharmacological Effects of Psychedelic Drugs.ACS chemical neuroscience · 2026-08-05Feasibility Phase 2 Study of Psilocybin-Assisted Therapy for Opioid-Refractory Pain in Patients With Advanced CancerClinicalTrials.gov · 2026-08-05Efficacy and risks of psychedelics in the treatment of posttraumatic stress disorder: A systematic review.American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists · 2026-08-05Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic TherapiesClinicalTrials.gov · 2026-08-04Psychedelics and women's mental health: the effects of female sex hormones on psychedelics' efficacy and tolerability.Molecular psychiatry · 2026-08-04Simulated 5-HT2A receptor activation accounts for the high complexity of brain activity during psychedelic statesbioRxiv · 2026-08-04Serotonergic psychedelics induce distinct patterns of metabolic activity and covariance within biologically informed rat brain networksNature Communications · 2026-08-03Music for Psilocybin Therapy and the Temporal Arc of Psychedelic ExperienceResearch Square · 2026-08-03Safety and Efficacy of Psilocybin During Anticancer Treatment: A Phase II Trial Secondary Analysis.Journal of pain and symptom management · 2026-08-03Where is the sweet spot for psychedelic-enhanced fear extinction? An integrative quantitative synthesis of dose-effect patterns in rodent models.Journal of psychopharmacology (Oxford, England) · 2026-08-03Psilocybin as a Treatment for Chronic Pain in SmokersClinicalTrials.gov · 2026-08-03Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility StudyClinicalTrials.gov · 2026-08-03Evaluating psilocybin for the management of depression: a literature reviewBritish Journal of Mental Health Nursing · 2026-08-02Psilocybin for Fear of Cancer RecurrenceSupportive Care in Cancer · 2026-08-01One Dose of Psilocybin May Alter Brain StructurePsychiatric News · 2026-08-01Cardiovascular safety of psilocybin in psychiatric practice: a narrative reviewEuropean Journal of Clinical Pharmacology · 2026-08-01